Unicef and Gavi agree to cut Mosquirix malaria vaccine price by 40%

Production to shift from GSK to Bharat Biotech as part of technology transfer

Unicef and Gavi agree to cut Mosquirix malaria vaccine price by 40%
Production to shift from GSK to Bharat Biotech as part of technology transfer